Latest imported 13F data
โณ
Showing Q1 2025 data
HedgeTrack has imported Q4 2025 data overall, but Springhill Fund Asset Management (HK) Co Ltd's latest available filing here is Q1 2025.

Springhill Fund Asset Management (HK) Co Ltd

โ€ขCIK: 1911270โ€ขFiling: Q1 2025

**Springhill Fund Asset Management (HK) Co Ltd** manages $21M across a concentrated portfolio of 19 positions. The fund exhibits significant exposure to biotechnology and healthcare, with top holdings including VRNA at $4.0M and SMMT at $2.4M. Further notable allocations include JANX ($2.1M) and REGN ($1.6M), indicating a focused, high-conviction approach within specialized sectors. This structure suggests active, deep-dive research into niche, high-growth life science opportunities.

Total AUM
$20.9M
QoQ Performance
-66.1%
Positions
19
Top 10 Concentration
82.9%
Latest Filing
Q1 2025

Top Holdings Allocation

VRNA
SMMT
JANX
REGN
NBIX
INSM
SLNO
JAZZ
VRNA19.3%
SMMT11.5%
JANX10.2%
REGN7.9%
NBIX7.2%
INSM7.0%
SLNO6.8%
JAZZ5.9%

๐Ÿ“ˆ Biggest Buys

SMMT
SUMMIT THERAPEUTICS INC
NEW
11.5% of portfolio
REGN
REGENERON PHARMACEUTICALS
NEW
7.9% of portfolio
NBIX
NEUROCRINE BIOSCIENCES INC
NEW
7.2% of portfolio
JANX
JANUX THERAPEUTICS INC
+165.2%
10.2% of portfolio
SLNO
SOLENO THERAPEUTICS INC
+1007.5%
6.8% of portfolio

๐Ÿ“‰ Biggest Sells

AKRO
AKERO THERAPEUTICS INC
-86.8%
3.9% of portfolio
VRNA
VERONA PHARMA PLC
-53.1%
19.3% of portfolio
INSM
INSMED INC
-72.4%
7.0% of portfolio
COGT
COGENT BIOSCIENCES INC
-94.6%
0.8% of portfolio

Sector Breakdown

Other96.8%
Healthcare3.2%

๐Ÿšช Exited Positionssold since Q4 2024

LEGN
LEGEND BIOTECH CORP
SOLD
$6.2M
CYTK
CYTOKINETICS INC
SOLD
$6.1M
AZN
ASTRAZENECA PLC
SOLD
$5.0M
VERA
VERA THERAPEUTICS INC
SOLD
$4.6M
2GH
MERUS N V
SOLD
$3.5M
+6 more exited positions

Changes from Q4 2024

NEW13 new positions
โ†‘2 increased
โ†“4 decreased

Historical Filings

Q1 2025Q4 2024